no statement of use filed
on 10 Feb 2020
Last Applicant/ Owned by
333 Ravenswood Avenue
Menlo Park
CA
94025
Serial Number
87855497 filed on 29th Mar 2018
Registration Number
N/A
Correspondent Address
ROCHELLE D ALPERT
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Laboratory equipment, namely, computer hardware, computer software and consumable cartridges sold empty for use in nucleic acid and genomic testing for scientific and research use Consumable cartridges sold pre-filled with reagents for use in nucleic acid and genomic testing for medical diagnostic use Consumable cartridges sold pre-filled with reagents for use in nucleic acid and genomic testing Read More
Consumable cartridges sold pre-filled with reagents for use in nucleic acid and genomic testing for scientific and research use
Consumable cartridges sold pre-filled with reagents for use in nucleic acid and genomic testing for medical diagnostic use
Laboratory equipment, namely, computer hardware, computer software and consumable cartridges sold empty for use in nucleic acid and genomic testing for scientific and research use
Medical equipment, namely, consumable cartridges sold empty for use in nucleic acid and genomic testing for medical diagnostic use, and computer hardware and computer software for use therewith sold as a unit
Scientific research and development in the field of precision medicine
No 87855497
No Service Mark
No 115739.2010
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
10th Feb 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
10th Feb 2020 | ABANDONMENT - NO USE STATEMENT FILED |
09th Jul 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
14th May 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
14th May 2019 | PUBLISHED FOR OPPOSITION |
24th Apr 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
19th Mar 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
16th Mar 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
15th Mar 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
15th Mar 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |